cilostazol has been researched along with Age-Related Memory Disorders in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we tested whether cilostazol, a selective PDE3 inhibitor, prevents the cognitive deterioration that occurs during the course of normal aging in mice." | 3.88 | Long-term cilostazol administration prevents age-related decline of hippocampus-dependent memory in mice. ( Endo, S; Ito, H; Yanai, S, 2018) |
| "Cilostazol was administered to rats intraperitoneally at dose 3 mg/kg." | 1.51 | The effect of cilostazol on hippocampal memory and oxidative stress biomarkers in rat model of diabetes mellitus. ( Ababneh, MA; Alzoubi, KH; Athamneh, RY; Mardini, AN; Rababa'h, AM, 2019) |
| " Long-term administration of cilostazol restored the impaired context-dependent conditioned fear memory of SAMP8 to match that in normal aging control substrain SAMR1." | 1.46 | Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier. ( Endo, S; Ishiwata, K; Ito, H; Toyohara, J; Yanai, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yanai, S | 2 |
| Ito, H | 2 |
| Endo, S | 2 |
| Rababa'h, AM | 1 |
| Mardini, AN | 1 |
| Alzoubi, KH | 1 |
| Ababneh, MA | 1 |
| Athamneh, RY | 1 |
| Toyohara, J | 1 |
| Ishiwata, K | 1 |
3 other studies available for cilostazol and Age-Related Memory Disorders
| Article | Year |
|---|---|
Long-term cilostazol administration prevents age-related decline of hippocampus-dependent memory in mice.
Topics: Age Factors; Aging; Animals; Cilostazol; Conditioning, Classical; Exploratory Behavior; Hippocampus; | 2018 |
The effect of cilostazol on hippocampal memory and oxidative stress biomarkers in rat model of diabetes mellitus.
Topics: Animals; Brain-Derived Neurotrophic Factor; Catalase; Cilostazol; Diabetes Mellitus, Experimental; G | 2019 |
Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier.
Topics: Aging; Amygdala; Animals; Blood-Brain Barrier; Capillary Permeability; Cilostazol; Conditioning, Cla | 2017 |